NICE Overturns Bavencio Rejection After Merck/Pfizer Win Appeal On English Funding

Over 800 People With Urothelial Cancer Set To Benefit From Bavencio

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".